A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice
about
Alterations in postnatal neurogenesis and dopamine dysregulation in schizophrenia: a hypothesisD2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHDControl of sleep and wakefulnessIdentification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatumNeurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient miceReversal of the circadian expression of tyrosine-hydroxylase but not nitric oxide synthase levels in the spinal cord of dopamine D3 receptor knockout miceConversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out miceDisruption of the dopamine D3 receptor gene produces renin-dependent hypertensionEssential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptorsLentiviral-mediated gene delivery reveals distinct roles of nucleus accumbens dopamine D2 and D3 receptors in novelty- and light-induced locomotor activitySimultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice.Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primateThe neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gatingAbnormal neuronal activity in Tourette syndrome and its modulation using deep brain stimulationDysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout miceDopamine, kidney, and hypertension: studies in dopamine receptor knockout mice.Behavioral actions of alcohol: phenotypic relations from multivariate analysis of mutant mouse data.Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes.Dopamine D3 receptors in rat juxtaglomerular cells.A behavioral genetics approach to understanding D1 receptor involvement in phasic dopamine signaling.Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsHabituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors.Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes.Neuroanatomical phenotyping in the mouse: the dopaminergic system.Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspironeThe role of dopamine receptors in the neurobehavioral syndrome provoked by activation of L-type calcium channels in rodents.Increased vulnerability to cocaine in mice lacking dopamine D3 receptorsThe D3 dopamine receptor and substance dependence.Toward a molecular understanding of psychostimulant actions using genetically engineered dopamine receptor knockout mice as model systems.Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects predictionDopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosisDopamine receptor mediation of the exploratory/hyperactivity effects of modafinil.Dopamine genes and attention-deficit hyperactivity disorder: a review.Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma.Dopamine receptors and Parkinson's diseaseβ-arrestin2 plays permissive roles in the inhibitory activities of RGS9-2 on G protein-coupled receptors by maintaining RGS9-2 in the open conformation.Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine.Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features
P2860
Q24606423-FDA73E7C-3C05-47CE-8C8C-7D59CEC0345AQ24627768-D6A790EF-2559-4AE0-BB4D-FFF0F14F3659Q24634619-0077F28C-6968-4629-8F15-AB5C0F10BE0FQ24651562-BC0F6070-2ED9-4583-9D4B-D31BAE5615F4Q28345182-C0F6987C-0482-4E52-8D18-1F88DF9400E3Q28505396-9B7957C8-322D-4068-8257-4D1BCF3E9B66Q28508917-75889391-BCF7-450A-A0A8-2212031AF51AQ28511119-5D9444CC-3083-45C1-AB44-AEFFE0C76844Q28513861-6D89A6D3-2D75-4623-953B-6061CF6F9C36Q28579950-69AC5A51-82F2-4509-9E18-1BC825104A10Q28595051-DDE423CC-6EC3-4929-8907-7085DDB07A2FQ28748883-2757C239-B4DE-4C00-9FDC-FB95BF070E64Q30367021-29005ACA-5E1A-4243-A20F-20F8B2BC66B4Q30380379-ADB79A5B-5159-4025-B4FE-0111B1A34520Q30412976-F6C7E941-3086-4E16-8EDE-E99F1D505BE1Q30418084-9EF15352-D884-4E55-8DE7-60A83C375401Q30454005-FC7C7AA7-5016-4EC8-922B-441FA330D724Q30465985-725F5042-E658-49F6-B15C-606A3AEC8E23Q30470013-DAC16A07-59A1-4960-8424-51FEB23ABD34Q30474975-305F00CC-5B6B-44D2-B2E7-A620A3116D1DQ30476813-0029EC27-7763-4A92-AAFD-F2403F565CF3Q30479796-9CF308D4-E4B2-4442-B66D-B08069ECC55AQ31913355-D46590F5-71B6-41DE-AF7F-7FC8943AE41BQ33227606-8C418FC6-37E2-4623-8446-8D55E5F3E766Q33764334-EC8871E9-60F5-405A-B946-88C333418940Q34181980-0EEBB9FD-D058-4BCC-A549-05D34E0909D0Q34304643-409FF984-5764-40EA-8683-8F0485AFD51CQ34420270-D2CE7F9C-59FF-4461-B5EA-E00EC7A0E8BDQ34420295-4588A7DD-EAC3-4352-B205-A93CB5B4ECD3Q34676533-6C55D42E-0ECD-4855-B4B9-2500672994EFQ34883582-8817FABD-F19C-479D-9AE4-1A0699085430Q34983783-CA812D1D-3AB2-4A91-814A-C5C70A9A0FCCQ34988400-F0A39D9E-830B-461F-87E9-0053BECFD56DQ35066854-45050912-B1B0-47A1-B5FD-80758EDFB41AQ35128618-454791ED-4509-4850-BABE-8212C91CC31EQ35545020-ADE7D43D-846B-444D-AD67-7C57890EFB39Q35599100-94CB454E-AE5C-4DF1-B03A-67B6FE1A3DEEQ35669953-CC5842F2-FD14-477D-9641-3D80FFB67B75Q35669960-278E3BDE-4F0C-4B50-B599-9130582659F7Q35682160-BCDA7A1B-51B3-4426-B11C-2DAEF51B17F4
P2860
A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice
description
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1996
@ast
im März 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/03/05)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/03/05)
@nl
наукова стаття, опублікована в березні 1996
@uk
name
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@ast
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@en
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@nl
type
label
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@ast
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@en
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@nl
prefLabel
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@ast
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@en
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@nl
P2093
P2860
P356
P1476
A targeted mutation of the D3 ...... ted with hyperactivity in mice
@en
P2093
B. H. Park
C. R. Gerfen
C. S. Fishburn
D. R. Sibley
E. B. Gauda
H. Steiner
H. Westphal
P2860
P304
P356
10.1073/PNAS.93.5.1945
P407
P577
1996-03-05T00:00:00Z